Abstract
BackgroundIn routine care, patients with active RA usually undergo treatment with TNF inhibitors. The choice of the durg is empirical and there are not established predictors of long-term clinical outcomesObjectivesTo...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have